Aurobindo Pharma Gets USFDA Nod to Market Ramipril Tablets

by Kathy Jones on  June 11, 2011 at 5:54 PM Corporate News
RSS Email Print This Page Comment bookmark
Font : A-A+

Hyderabad based pharmaceutical company, Aurobindo Pharma has revealed that it has got the approval from the US Food and Drug Administration to manufacture and market its hypertension drug, ramipril in the country.
 Aurobindo Pharma Gets USFDA Nod to Market Ramipril Tablets
Aurobindo Pharma Gets USFDA Nod to Market Ramipril Tablets

Apart from high blood pressure, ramipril is also used in treating congestive heart failure (CHF) and the company said that it has gained approval to manufacture the drug in 1.25mg, 2.5mg, 5mg and 10mg strengths.

Recent figures released by the IMS have shown that the cardiovascular therapeutic segment in the United States generated sales of over $95 million in the year ending September 2010.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Congestive Heart Failure 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

Advertisement

News Category

News Archive